AU2002236455A1 - Synergistic ecta compositions - Google Patents
Synergistic ecta compositionsInfo
- Publication number
- AU2002236455A1 AU2002236455A1 AU2002236455A AU3645502A AU2002236455A1 AU 2002236455 A1 AU2002236455 A1 AU 2002236455A1 AU 2002236455 A AU2002236455 A AU 2002236455A AU 3645502 A AU3645502 A AU 3645502A AU 2002236455 A1 AU2002236455 A1 AU 2002236455A1
- Authority
- AU
- Australia
- Prior art keywords
- ecta
- synergistic
- compositions
- synergistic ecta
- ecta compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
- A61K47/556—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells enzyme catalyzed therapeutic agent [ECTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/66—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells
- A61K47/67—Enzyme prodrug therapy, e.g. gene directed enzyme drug therapy [GDEPT] or VDEPT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24972200P | 2000-11-16 | 2000-11-16 | |
US60/249,722 | 2000-11-16 | ||
PCT/US2001/043566 WO2002039952A2 (en) | 2000-11-16 | 2001-11-16 | Synergistic ecta compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002236455A1 true AU2002236455A1 (en) | 2002-05-27 |
Family
ID=22944709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002236455A Abandoned AU2002236455A1 (en) | 2000-11-16 | 2001-11-16 | Synergistic ecta compositions |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020147175A1 (en) |
AU (1) | AU2002236455A1 (en) |
WO (1) | WO2002039952A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU9016998A (en) * | 1997-08-08 | 1999-03-01 | Newbiotics, Inc. | Methods and compositions for overcoming resistance to biologic and chemotherapy |
US7462605B2 (en) * | 1998-01-23 | 2008-12-09 | Celmed Oncology (Usa), Inc. | Phosphoramidate compounds and methods of use |
CN1192102C (en) * | 1998-01-23 | 2005-03-09 | 新生物生物公司 | Enzyme catalyzed therapeutic agents |
JP2003525866A (en) * | 1999-07-22 | 2003-09-02 | ニューバイオティックス インコーポレイテッド | Methods for treating refractory tumors |
US6683061B1 (en) * | 1999-07-22 | 2004-01-27 | Newbiotics, Inc. | Enzyme catalyzed therapeutic activation |
US20030212037A1 (en) * | 2000-12-21 | 2003-11-13 | Christopher Boyer | Use of bvdu for inhibiting the growth of hyperproliferative cells |
GB0317009D0 (en) | 2003-07-21 | 2003-08-27 | Univ Cardiff | Chemical compounds |
DE102006037786A1 (en) * | 2006-08-11 | 2008-03-20 | Resprotect Gmbh | Nucleosides, pharmaceuticals containing them and their use |
WO2014135107A1 (en) * | 2013-03-08 | 2014-09-12 | 南京圣和药业有限公司 | Novel nucleoside phosphoramidate compound and use thereof |
CN110731962B (en) * | 2018-07-18 | 2022-05-20 | 中国医学科学院药物研究所 | Application of berberine, coptisine or active metabolites thereof, and salts thereof in drugs for preventing and/or treating uric acid nephrosis |
BE1026612B1 (en) * | 2018-09-27 | 2020-07-02 | Iteos Therapeutics S A | USE OF AN ENT FAMILY CARRIER INHIBITOR IN THE TREATMENT OF CANCER AND COMBINATION THEREOF WITH AN ADENOSINE RECEPTOR ANTAGONIST |
-
2001
- 2001-11-16 US US09/990,799 patent/US20020147175A1/en not_active Abandoned
- 2001-11-16 AU AU2002236455A patent/AU2002236455A1/en not_active Abandoned
- 2001-11-16 WO PCT/US2001/043566 patent/WO2002039952A2/en active Search and Examination
Also Published As
Publication number | Publication date |
---|---|
US20020147175A1 (en) | 2002-10-10 |
WO2002039952A2 (en) | 2002-05-23 |
WO2002039952A3 (en) | 2002-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU781269C (en) | Pharmaceutical compositions | |
AU2001234509A1 (en) | Antimicrobial compositions | |
AU2001250420A1 (en) | Pharmaceutical compositions | |
AU2001274307A1 (en) | Pharmaceutical compositions | |
AU2001282617A1 (en) | Compositions for external preparations | |
AUPQ875700A0 (en) | Combination compositions | |
AU2001268953A1 (en) | Antimicrobial compositions | |
AU2002214324A1 (en) | Medicinal compositions | |
AU2001266945A1 (en) | Synergistic biocidal compositions | |
AU2002219080A1 (en) | Cleaning compositions | |
AU2001241098A1 (en) | Composition | |
AU2002236455A1 (en) | Synergistic ecta compositions | |
AU2001273919A1 (en) | Pharmaceutical compositions | |
AU2681500A (en) | Rapidly-soluble compositions | |
AU2002210433A1 (en) | Dental compositions | |
AU2001270235A1 (en) | Oral compositions | |
AUPQ634300A0 (en) | Synergistic formulations | |
AU5085300A (en) | Compositions | |
AU2001275201A1 (en) | Acne-treating composition | |
AU2001259252A1 (en) | Neuroprotective compositions | |
AU2001287852A1 (en) | Composition | |
AU2001235764A1 (en) | Compositions | |
AU2001290669A1 (en) | Oral compositions | |
AU2001223721A1 (en) | Dental compositions | |
AUPQ755300A0 (en) | Immune potentiating compositions |